Latest News & Features
Americas
As John Squires makes the bold move to allow patentability of an AI-related invention in Ex parte Desjardins, patent experts broadly welcome the decision—but encourage some caution, finds Sarah Speight. 2 October 2025
Americas
Research reveals an increase in global filings in 2024/2025, but concerns remain over the future of vaccine development in the US. 1 October 2025
Americas
The healthtech giant has convinced a US court to freeze the assets of two Chinese startups and their ex-employees for breaching an injunction for trade secret theft of X-ray tubes used in CT scanners. 1 October 2025
Careers
Duo have a combined 60 years of experience in patent litigation, prosecution, and patent portfolio management across mechanical, electrical, medical devices, chemical and pharmaceutical tech. 30 September 2025
Europe
A landmark decision sees the European Patent Office confirm that once all original appeals are withdrawn, third-party interveners cannot continue proceedings. 30 September 2025
Americas
Complaint alleges the pair used Massachusetts company’s patented mRNA TALEN gene-editing technology without permission in multi-billion-dollar cancer therapy deals. 29 September 2025
Americas
Sweeping tariffs send shockwaves through the pharma sector, as experts warn of consumer detriment and supply chain risks. 26 September 2025
Europe
A new survey from LSIPR reveals that European patent practitioners are grappling with client budget constraints and fast-evolving technologies, with most expecting patenting challenges to increase over the next five years. 25 September 2025
Europe
The General Court has handed a win to generic drug makers including Teva and Mylan in the battle over multiple sclerosis drug Tecfidera. 25 September 2025
Careers
The firm’s Technology & Engineering team will be expanded with an expert in patent drafting, prosecution and opposition/defence work across AI, digital health and medical devices. 25 September 2025